Safty and efficacy of autologuous adipose tissue derived mesenchymal stem cell infusion therapy on liver cirrhosis
Phase 1
Recruiting
- Conditions
- liver cirrhosis
- Registration Number
- JPRN-UMIN000036136
- Lead Sponsor
- Kyushu university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Not provided
Exclusion Criteria
A.alcoholic patients B.sever heart disease C.pregnant patients D.malignant tumor such as HCC E.uncontrolled infectious disease F.impossible to obtain an informed consent I.The patient who primary investigator judged unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method General status, D-dimer, FDP, respiratory function, organ function are evaluated at 1,3.7,14,30,90,and 360 days after infusion of ADSC.
- Secondary Outcome Measures
Name Time Method